Evidence map›Paper›PMID 39895402›Full record

ArticleCancers2025

Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis.

Flavia Fondevila, Paula Fernández-Palanca, Carolina Méndez-Blanco, Tania Payo-Serafín, Elisa Lozano, Jose J G Marin, Javier González-Gallego, José L Mauriz

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Flavia FondevilaInstitute of Biomedicine (IBIOMED), University of León, Campus de Vegazana s/n, 24071 León, Spain.ORCID 0000-0003-2881-704X
Paula Fernández-PalancaInstitute of Biomedicine (IBIOMED), University of León, Campus de Vegazana s/n, 24071 León, Spain.ORCID 0000-0001-9765-9562
Carolina Méndez-BlancoInstitute of Biomedicine (IBIOMED), University of León, Campus de Vegazana s/n, 24071 León, Spain.ORCID 0000-0001-6378-2554
Tania Payo-SerafínInstitute of Biomedicine (IBIOMED), University of León, Campus de Vegazana s/n, 24071 León, Spain.ORCID 0000-0003-2245-6992
Elisa LozanoCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0002-7714-1691
Jose J G MarinCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0003-1186-6849
Javier González-GallegoInstitute of Biomedicine (IBIOMED), University of León, Campus de Vegazana s/n, 24071 León, Spain.ORCID 0000-0002-4386-9342
José L MaurizInstitute of Biomedicine (IBIOMED), University of León, Campus de Vegazana s/n, 24071 León, Spain.ORCID 0000-0003-3160-8599

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39895402
PMCPMC11788589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.